Barcelona-based Nuage Therapeutics has announced key leadership appointments with Dr. Stuart Hughes joining as CEO and Vanessa Malier as Chair, as the company advances its platform for targeting previously undruggable oncogenic transcription factors through novel technology addressing intrinsically disordered proteins.
Dr. Alfred Merz has been appointed Chief Executive Officer at Berlin-based ProBioGen, a contract development and manufacturing organisation specialising in biopharmaceuticals, viral vectors and vaccines. The appointment signals a strategic realignment within the company as it seeks to leverage Dr. Merz’s extensive pharmaceutical background to accelerate growth in the competitive biologics market.
Source BioScience UK Ltd has completed the acquisition of Cambridge Clinical Laboratories (CCL), establishing a more comprehensive clinical diagnostics portfolio that aims to streamline testing services across the research and clinical spectrum. The transaction, announced on 10 April 2025, will see CCL staff and assets relocated to new clinical laboratory facilities at Source BioScience’s Vision […]
Computer simulations reveal previously unknown access points in cell membrane proteins that could lead to more targeted therapeutic approaches for a range of conditions.
Researchers have created a detailed map of adeno associated virus distribution in mice to improve targeting efficiency and reduce off-target effects in gene therapy applications.
VectorY Therapeutics, an emerging biotechnology company focused on vectorized antibody therapies for neurodegenerative diseases, has appointed Dr. Olga Uspenskaya-Cadoz as Chief Medical Officer (CMO). The strategic appointment comes at a pivotal moment as the company prepares to submit an Investigational New Drug (IND) application for its lead candidate, VTx-002, for sporadic amyotrophic lateral sclerosis (ALS) […]
Revvity, Inc. has significantly expanded its collaboration with Genomics England to provide comprehensive genomic screening services for newborns in England. The new agreement builds upon an existing partnership by adding DNA sequencing services to Revvity’s current DNA extraction capabilities.
Bio-Rad Laboratories has achieved a significant regulatory milestone with EU Quality Management Systems certification under the In Vitro Diagnostic Regulation (IVDR), enabling CE marking for 40 infectious disease molecular quality control products from their Exact Diagnostics brand.
FairJourney Biologics S.A., a global leader in antibody discovery and development based in Porto, Portugal, has announced the formation of a new Supervisory Board aimed at enhancing the company’s strategic positioning and accelerating innovation in antibody research. The board, comprising distinguished industry veterans with extensive expertise in biopharmaceutical development, will focus on defining key growth […]
The equity-free accelerator programme, based in Basel’s life sciences hub, aims to address the 80% failure rate of healthtech startups by providing direct access to pharmaceutical expertise and resources.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
